Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...